Home / The Injection Room / How do I document product lot numbers so a recall or an adverse event does not sink me?

practical guide

How do I document product lot numbers so a recall or an adverse event does not sink me?

Lot capture is the thread connecting a vial to a patient to a manufacturer notice. This is the workflow that makes traceability survive a busy day and an FDA MedWatch report.

Gloved hands holding a small vial next to an open log on a white clinical tray
Gloved hands holding a small vial next to an open log on a white clinical tray

You document lot numbers so that a single question can be answered in minutes rather than days: which of my patients received product from this batch. That question arrives in one of two ways. Either a manufacturer or the FDA announces a recall or a field correction, or one of your patients develops a delayed nodule and someone asks what exactly went into her face on a Tuesday last spring.

The workflow that survives both is not complicated. It is capture at draw up, tied to the patient, with expiration and site included, and reconciled against inventory on a schedule. What sinks practices is the habit of writing lot numbers on a paper log at the end of the day, when four patients have blurred together and the box is already in the sharps bin.

Here is how to build the thread that connects a vial to a patient to a manufacturer notice, without adding minutes to a room you need to turn over.

What traceability means when a manufacturer issues a recall

Dermal fillers and botulinum toxins are regulated devices and biologics with lot level manufacturing controls. When something goes wrong at the manufacturing level, whether contamination, a labeling error, a packaging defect or a cold chain excursion during distribution, the corrective action is scoped by lot. The notice names specific lot numbers and expiration dates. It does not name clinics or patients. That part is your job.

A recall notice typically asks a practice to do three things: quarantine unused product from the named lots, return or destroy it per instruction, and notify patients who received it. The third obligation is where record quality becomes visible. If your only record is a distributor invoice showing you bought twelve syringes of that lot, you know you have exposure and nothing more.

There is a second, quieter reason to keep lot records tight. Product authenticity. Practices that have bought from grey market sources have found themselves unable to match a lot number to any legitimate manufacturing run, and that discovery tends to happen in front of a board investigator. Buying direct from the manufacturer or an authorized distributor and recording lot at point of use is how you demonstrate chain of custody.

Keep reading: Why do so many med spas fail their first state board inspection, and what gets flagged?

The five data points to capture per vial or syringe

Everything else is optional. These five are not.

FieldExampleWhy it is needed
Product and brandHyaluronic acid filler, specific brand and formulationRecalls are brand and formulation specific
Lot or batch numberPrinted on the carton and the syringe or vial labelThe only field a recall notice matches on
Expiration dateMonth and year from the labelDistinguishes lots that share a partial number, proves in date use
Volume or units used0.7 mL of a 1.0 mL syringe, or 24 unitsDose reconstruction for adverse event reporting
Anatomic siteRight nasolabial fold, deep dermalTies a complication to a specific product placement

Two habits make these fields more useful. Record volume used and volume discarded separately, because a partially used syringe that gets discarded is a cost line and an inventory reconciliation item. And record the site with laterality and plane, not just a region name. When a patient returns at week six with a firm area, the difference between supraperiosteal and subdermal placement changes your management.

Where the number actually lives

On most filler syringes the lot appears on the carton, on a peel off label attached to the syringe barrel, and on the pre printed patient record stickers the manufacturer supplies. Those stickers exist precisely for this. Peel one into the chart, one into your log, and one for the patient if she wants it. On toxin vials the lot is printed on the vial label and the carton, and the vial label is small enough that reading it under treatment room lighting through a face shield is a genuine failure point.

Capturing the lot at draw up, not at the end of the day

The rule is simple: the lot is recorded while the product is in your hand and the packaging is intact. Not after. Once the carton is in the trash and the syringe is in the sharps container, the number is gone, and the reconstruction you do at 6 p.m. is a guess written in ink.

A sequence that works in a real room:

  1. Bring the sealed product into the room in front of the patient. This doubles as authenticity assurance she can see.
  2. Before opening, capture the lot and expiration. Photograph the label or scan the barcode, or peel the sticker into the record.
  3. Confirm the product against the order: right brand, right formulation, in date.
  4. Draw up or attach the needle, treat, and record volume or units per site as you go, not from memory afterward.
  5. Record discard volume before the syringe leaves your hand.

Photographing the label is the highest yield change most practices can make, because it takes about four seconds and produces a record no one can dispute. Transcription errors in lot numbers are common: they are long alphanumeric strings, often with characters that look alike in small print. A photograph is not a transcription.

Keep reading: Should I charge per unit or per area for neuromodulators, and how do the two models compare?

Reconciling opened inventory against treated patients

Reconciliation is the check that catches missing records before an inspector or a recall does. Run it against a defined period, weekly is realistic, and compare three counts.

  • Units or syringes received for a given lot, from purchase records.
  • Units or syringes administered for that lot, summed from patient records.
  • Units or syringes remaining on the shelf or in the refrigerator, from a physical count.

Received minus administered minus remaining should equal documented waste. Anything left over is an undocumented treatment, a miscount, or product that left the building. Consider a small worked example, using assumed numbers to show the arithmetic rather than to describe any real clinic.

Assume you received 10 syringes of one lot. Patient records account for 7 syringes fully used and 2 partially used with waste noted. Physical count shows 1 remaining. That reconciles: 10 minus 9 administered minus 1 on hand equals 0 unaccounted. Now assume physical count shows 0 remaining instead. You have one syringe with no record at all, and if that lot is later recalled you cannot tell whether it went into a patient. That is the gap worth finding on a Friday rather than in a legal hold.

Filing a MedWatch report and what it asks for

MedWatch is the FDA's safety reporting program, and voluntary reports from practitioners are submitted on Form 3500. For serious adverse events associated with a device or biologic, reporting is the responsible course, and some events carry mandatory reporting obligations for user facilities depending on the product classification and your state.

The form asks for the things you either recorded or did not. Product brand name and manufacturer. Lot number. Expiration date. Dose and route. Dates of use and of the event. A narrative describing the event, its outcome, and relevant history including concurrent products and medical conditions. Whether the product is still available for evaluation.

That last item is worth planning for. If you suspect a product related event, keep the packaging and any remaining product, bagged and labeled, rather than discarding it. A manufacturer investigating a complaint will often request the unit, and a returned syringe with its carton is far more useful than a description.

You do not need certainty of causation to report. The standard is suspicion of an association, and the narrative should describe what happened without asserting a mechanism you cannot support.

See how InjectConsent handles this for medical aesthetics and injectables

Handling reconstituted toxin across multiple patients

Reconstituted botulinum toxin creates a documentation problem fillers do not have, because one vial becomes several patients. The chain has to carry from vial to syringe to person.

What that requires in practice: record the lot and expiration of the vial once, record the diluent used and the dilution ratio, record the date and time of reconstitution, and then attach that same vial identifier to every patient dosed from it. If you reconstitute two vials of different lots on the same day, you need to know which patient got which, which means labeling the drawn syringes rather than relying on order of use.

Follow the manufacturer's labeling on storage and use after reconstitution, and record the discard time you are working to. If a state inspector asks how you manage multi patient vials and your answer is a shrug, that is a finding regardless of whether anything went wrong.

Auditing your own records once a quarter

Pull ten treatment records at random from the last three months and score each one against a fixed checklist. It takes about half an hour and it tells you where the workflow is leaking.

  • Lot number present and legible for every product administered.
  • Expiration date present, and in date on the treatment date.
  • Dose recorded per site, not as a total.
  • Sites recorded with laterality.
  • Waste documented where a partial unit was used.
  • Consent signed and dated on that visit date.
  • Before photographs present and attached to that visit.

Score by count of complete records, not by impression. Nine of ten with one missing expiration date is a training reminder. Six of ten is a system problem, and no amount of asking staff to be careful will fix a system problem.

The practical next step

The reason lot capture fails is almost never that anyone thinks it is unimportant. It fails because it competes with a patient in the chair and a schedule running eight minutes behind. The fix is to move capture inside the treatment moment, where the packaging is still in your hand, rather than after it.

InjectConsent puts lot capture, the signed consent and the before photograph into the same two minute sequence as the treatment, ties every lot to the patient and the mapped site, and gives you a record you can search by lot when a notice lands. Build the thread once, and the recall question becomes a query instead of a weekend.